駿利亨德森資產管理基金 - 駿利亨德森環球生命科技基金 V2 歐元避險

14.49歐元0.43(3.06%)
2022/11/30更新
績效 / 
1月2.48%
3月5.56%
1年4.48%
晨星評等
-

基本資料

基金公司/總代理人
駿利亨德森證券投資顧問股份有限公司
註冊地
愛爾蘭
計價幣別
歐元
基金組別
產業股票 - 其他
基金家族
Janus Henderson Investors
公開說明書基準指數
-
晨星組別基準指數
MSCI World/Health Care NR USD
基金規模
3,855.96百萬截至 2022-11-29
年初至今報酬率
8.82%
殖利率
0.00
晨星評等
-
成立日期
2015-10-16

投資策略

本基金之投資目標是資本的長期增值。基金主要投資於世界各地生物科技領域具有成長潛質的上市公司。

投資九宮格

大型
中型
小型
價值型均衡型增長型

基金經理人

  • Acker Andrew
  • 資歷 16年(2007-05-01 至今)
  • Andy Acker is a Portfolio Manager at Janus Henderson Investors responsible for managing the Global Life Sciences and Biotechnology strategies since 2007 and 2018, respectively. He also leads the firm’s Health Care Sector Research Team. Andy was assistant portfolio manager on the Global Life Sciences strategy from 2003 to 2007. He joined Janus in 1999 as a research analyst focused on companies in the biotechnology and pharmaceutical industries. Prior to this, he worked as a strategy consultant for the Boston Consulting Group and as a health care analyst for Morgan Stanley Venture Partners. Andy received his bachelor of science degree in biochemical sciences from Harvard University, graduating magna cum laude and Phi Beta Kappa. He also earned an MBA with honours from Harvard Business School. Andy holds the Chartered Financial Analyst designation and has 23 years of financial industry experience.

基金費用

最低認購金額
2,500歐元
申購手續費
-
保管費
-
分銷費
-
管理費
-
最高管理費
1.50%
遞延費
-
最高遞延費
3.00%

聯絡資訊

基金投資顧問
駿利亨德森證券投資顧問股份有限公司
聯絡電話
(886) 02 8101-1001
基金顧問地址
台北市信義路五段7 號台北101大樓45樓A-1室
基金顧問網址
zh-tw.janushenderson.com/taiwan/intermediary